As American public health officials and political leaders worked to persuade more young people to accept the COVID-19 vaccine, researchers discovered a disturbing effect of Pfizer and Moderna jabs, which relies on new mRNA technology to program the body to fight viruses. While adenovirus-vector jabs like the AstraZeneca shot have been linked to many fatal cerebral blood clots, mRNA vaccines are now found to cause heart inflammation in some patients.
We first understood later this past week when the CDC announced that it would be holding an “emergency meeting” about the increasing number of heart inflammation cases in the U.S. VAERs database.
According to Reuters, the CDC began an investigation after Israel’s Health Ministry reported they discovered a likelihood related to the condition of young men who received Pfizer jab. Even if some patients were hospitalized, most recovered on their own and (more importantly) none died.
The CDC told Reuters they are still investigating the risk from the condition and have not yet concluded that there is a significant link between vaccines and cases of myocarditis or pericarditis. However, there are some lingering indications that the potential side effects from vaccines are higher for young people. More than 50% of cases reported by the U.S. Vaccine Adverse Event Reporting System – better known as VAERS – after people received their second dose of jab were in people aged 12 to 24, according to the CDC. Those age groups accounted for less than 9% of the dose administered.
“We have a clear imbalance there,” Drs. Tom Shimabukuro, deputy director of the CDC’s Immunization Safety Office, in a presentation to an agency advisory committee on Thursday. Most of these cases arose within a week of vaccination. Shimabukuro added that doctors found a “preponderance” in young white men. This is in contrast to AstraZeneca’s brain tumors, in which many women suffer. Just under 80% of all these cases are found in men.
Scientists know something is wrong because, according to VAERS, there were 283 observed cases of heart inflammation after the second dose of the vaccine in patients aged 16 to 24. This was compared to expected 10-to-102 cases in all age groups based on demographic data. – READ MORE